Innoviva
INVA
#5721
Rank
NZ$2.38 B
Marketcap
NZ$33.61
Share price
-2.84%
Change (1 day)
-13.08%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): NZ$0.38 Billion

According to Innoviva's latest financial reports the company's current earnings are NZ$0.43 Billion. In 2025 the company made an earning of NZ$0.59 Billion, an increase over its 2024 earnings that were of NZ$67.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.38 B-35.93%
2025 NZ$0.59 B774.24%
2024 NZ$67.97 M-80.74%
2023 NZ$0.35 B-32.36%
2022 NZ$0.52 B-35.56%
2021 NZ$0.80 B25.7%
2020 NZ$0.64 B52.11%
2019 NZ$0.42 B10.77%
2018 NZ$0.38 B56.59%
2017 NZ$0.24 B125.53%
2016 NZ$0.10 B-417.36%
2015 -NZ$34.11 Million-74.49%
2014 -NZ$0.14 Billion-25.19%
2013 -NZ$0.18 Billion430.06%
2012 -NZ$33.71 Million-83.92%
2011 -NZ$0.21 Billion39.82%
2010 -NZ$0.15 Billion2.84%
2009 -NZ$0.15 Billion-8.62%
2008 -NZ$0.16 Billion-47.92%
2007 -NZ$0.31 Billion-5.92%
2006 -NZ$0.33 Billion19.8%
2005 -NZ$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.29 Billion-171.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.01 Million-108.11%๐Ÿ‡บ๐Ÿ‡ธ USA